Pharma Stocks
-
Stocks to watch, Sept 7: 3 Tata group cos, 4 Railway stocks, 2 shipping sector, 3 Pharma majors, Adani Enterprises, NMDC, SJVN, Nava, Stanley Lifestyle will remain in focus
HyperVault, a subsidiary of Tata Consultancy Services (TCS), on Saturday announced that it has secured 264 acres of land in…
Read More » -
ANI Pharmaceuticals (ANIP), Why Is Fresh Attention Building Around It?
Board changes and upcoming investor appearances frame ANI Pharmaceuticals stock story ANI Pharmaceuticals (ANIP) recently added experienced dealmaker Henry Gosebruch…
Read More » -
Arrowhead Pharmaceuticals (ARWR) Stock Looks Cheap On Cash Flow Yet Fair On Sales
Arrowhead Pharmaceuticals has delivered a very strong 197.0% 1 year return, yet the latest valuation checks point to a more…
Read More » -
Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets
Price targets for Hikma Pharmaceuticals are currently clustered in the £1,870 to £2,100 range, which sits above the latest fair…
Read More » -
Does Teva’s Celiac Drug Breakthrough and $500 Million Backing Redefine the Bull Case For TEVA?
Teva Pharmaceutical Industries recently reported positive topline results from a Phase 2a trial of its anti‑IL‑15 antibody TEV ‘408 in…
Read More » -
Fosun Pharma sells 4.55% stake in Gland Pharma for Rs 2,121 crore
Fosun Pharma Industrial sold a 4.55 per cent stake in Gland Pharma for Rs 2,121.50 crore through block deals, reducing…
Read More » -
Is Amphastar Pharmaceuticals (AMPH) Cheap After Its Recent Share Price Rebound?
Amphastar Pharmaceuticals (AMPH) stock has drawn investor attention after recent share price moves, including a gain over the past month…
Read More » -
3 Indian Pharma Stocks Riding The Export Story Investors Should Watch
India is reworking its place in global trade, with fresh FTAs and new market access shaping where the next wave…
Read More » -
How Elanco’s On-Time Kansas Biologics Expansion Will Impact Elanco Animal Health (ELAN) Investors
Elanco Animal Health has completed a 25,000-square-foot manufacturing expansion at its Elwood, Kansas site, a US$150 million project that boosts…
Read More » -
Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 crore
Promoter Fosun Pharma on Friday sold 98.97 lakh shares, equivalent to around 6% equity, in Gland Pharma for an estimated…
Read More »